Abstract
Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants may influence the effectiveness of existing laboratory diagnostics. In the current study we determined whether the British (20I/501Y.V1) and South African (20H/501Y.V2) SARS-CoV-2 variants of concern are detected with an in-house S1-based antigen detection assay, analyzing spiked pools of quantitative reverse-transcription polymerase chain reaction-negative nasopharyngeal swab specimens. The assay, combining 4 monoclonal antibodies, allowed sensitive detection of both the wild type and the variants of concern, despite accumulation of several mutations in the variants' S1 region - results suggesting that this combination, targeting distinct epitopes, enables both specificity and the universality.
Original language | English |
---|---|
Pages (from-to) | 616-619 |
Number of pages | 4 |
Journal | Journal of Infectious Diseases |
Volume | 224 |
Issue number | 4 |
DOIs | |
State | Published - 16 Aug 2021 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2021 The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].
Keywords
- 501Y.V1
- 501Y.V2
- Antibodies
- Antigen detection
- SARS-CoV-2
- Variants of Concern
- spike protein